• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

42
23
20
20
20

COUNTRY

20
1
1
1

CATEGORIES

  • 104
  • 44
  • 16
  • 16
  • 14
  • 10
  • 6
  • 6
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

48
65
153
223

PUBLISHED

3
17
52
223

PRODUCT TYPE

210
13

Search "Company Analysis - Biocon Limited" returned 223 results.

Biocon Limited (532523) - Financial and Strategic SWOT Analysis Review

Biocon Limited (532523) - Financial and Strategic SWOT Analysis Review Summary Biocon Limited (Biocon) is a fully integrated healthcare company engaged in the manufacturing of biopharmaceutical products...

April 2011
FROM

Biocon Limited - Product Pipeline Review - 2013

Biocon Limited - Product Pipeline Review - 2013 Summary “Biocon Limited - Product Pipeline Review - 2013” provides data on the Biocon Limited’s research and development focus. The report includes...

December 2013
FROM

Biocon Limited - Product Pipeline Review - 2014

Biocon Limited - Product Pipeline Review - 2014 Summary This, ‘Biocon Limited - Product Pipeline Review - 2014’, provides an overview of the Biocon Limited’s pharmaceutical research and development...

July 2014
FROM

Biocon Limited - Product Pipeline Review - 2012

Biocon Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - 2012” provides data on the Biocon Limited’s research...

August 2012
FROM

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The...

June 2015
FROM

BIOCON Limited Acquisition Manual

The Acquisition Manual on BIOCON Limited is published for two purposes, firstly to identify the company as a potential acquisition target and secondly, to fully analyse all aspects of Biocon so that...

July 2015

Biocon Limited - Product Pipeline Review - H2 2011

Biocon Limited – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - H2 2011” provides data on the Biocon Limited’s...

November 2011
FROM

Biocon Limited - Product Pipeline Review - Q4 2010

Biocon Limited – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - Q4 2010” provides data on the company’s research...

November 2010
FROM

Biocon Limited - Product Pipeline Review - Q4 2010

Biocon Limited – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - Q4 2010” provides data on the company’s research...

November 2010
FROM

Biotechnology in India - Global Business Strategic Report

This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors: Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services. Annual...

May 2012
FROM

Biocon Limited

A textual analysis of the financial results for Biocon Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses...

June 2015
FROM

Opportunity in the Indian Biopharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

This report provides an insight into the Opportunity in the Indian Biopharmaceuticals current market scenario, structure and practices. In depth market scenario includes: - Indian Biopharmaceuticals...

March 2015

India Biosimilar Market Analysis

As the number of patent expiries of biologic drugs is increasing, Indian companies are developing biosimilar manufacturing capabilities Firms are developing their capabilities by either forming partnerships...

August 2012
FROM

Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth

GBI Research, the leading business intelligence provider, has released its latest research “Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding...

January 2013
FROM

Opportunity in the Indian Anti-Diabetic Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

This report provides an insight into the Indian Anti-Diabetic Pharmaceuticals current market scenario, structure and practices. In depth market scenario includes: - Current market size estimate -...

March 2015

Opportunity in Biotechnology Industry in India - 2015 ; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

This report provides an insight into the Opportunity in Biotechnology Industry current scenario, structure and practices in India. In depth market scenario includes; - Current market size estimates -...

January 2015

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH,...

September 2013
FROM

Global Biosimilars: A return to optimism?

A Critical Strategic Analysis from Espicom Despite some commentators predicting a muted or near nonexistent market for advanced biosimilars, many companies – and some surprising names – are positioning...

January 2012
FROM

Biogenerics - Global Strategic Business Report

This report analyzes the worldwide markets for Biogenerics in US$ Million The report provides separate comprehensive analytics for the US, Europe, and Rest of World Annual forecasts are provided for...

July 2006
FROM

Vitiligo - Pipeline Review, H1 2014

Vitiligo - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Vitiligo - Pipeline Review, H1 2014’, provides an overview of the Vitiligo’s therapeutic pipeline. This report provides comprehensive...

April 2014
FROM
Loading Indicator

Our Clients

Hewlett-Packard Company Microsoft Corporation Philips N.V. SONY Corporation Cypress Semiconductor Corporation Panasonic Corporation